Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation
High levels of hepcidin, the main regulator of systemic iron metabolism, lead to various diseases. Targeting hepcidin and lowering its concentration is a possible form of intervention in order to treat these diseases. High turnover rate of hepcidin is a major drawback of therapies directly targeting...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 April 2015
|
| In: |
The AAPS journal
Year: 2015, Jahrgang: 17, Heft: 4, Pages: 930-938 |
| ISSN: | 1550-7416 |
| DOI: | 10.1208/s12248-015-9770-4 |
| Online-Zugang: | Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/10.1208/s12248-015-9770-4 Verlag, teilw. kostenfrei, Volltext: https://link.springer.com/article/10.1208/s12248-015-9770-4 
|
| Verfasserangaben: | Preethne Böser, Dietmar Seemann, Michael J. Liguori, Leimin Fan, Lili Huang, Mathias Hafner, Andreas Popp, and Bernhard K. Mueller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1567330754 | ||
| 003 | DE-627 | ||
| 005 | 20230426064453.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180118s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1208/s12248-015-9770-4 |2 doi | |
| 035 | |a (DE-627)1567330754 | ||
| 035 | |a (DE-576)49733075X | ||
| 035 | |a (DE-599)BSZ49733075X | ||
| 035 | |a (OCoLC)1340986023 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Böser, Preethne |d 1984- |e VerfasserIn |0 (DE-588)1103259148 |0 (DE-627)860870022 |0 (DE-576)47055679X |4 aut | |
| 245 | 1 | 0 | |a Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation |c Preethne Böser, Dietmar Seemann, Michael J. Liguori, Leimin Fan, Lili Huang, Mathias Hafner, Andreas Popp, and Bernhard K. Mueller |
| 264 | 1 | |c 22 April 2015 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.01.2018 | ||
| 520 | |a High levels of hepcidin, the main regulator of systemic iron metabolism, lead to various diseases. Targeting hepcidin and lowering its concentration is a possible form of intervention in order to treat these diseases. High turnover rate of hepcidin is a major drawback of therapies directly targeting this peptide. We developed two monoclonal antibodies ABT-207 and h5F9-AM8 which inhibit hemojuvelin/repulsive guidance molecule C (RGMc) and downregulate hepcidin. We conducted single-application and dose response studies to understand the antibodies’ mechanism and subchronic toxicology studies to exclude safety-related concerns. Investigation was carried out at different biological levels through qPCR, Affymetrix, liquid chromatography coupled with mass spectrometry (LC-MS/MS), histopathology, serum iron, unsaturated iron binding capacity (UIBC), and drug concentration measurements. After a single application of these antibodies, hepcidin expression in liver and its serum protein levels were reduced. Serum iron increased for several weeks. The RGMc antibodies show a pronounced dose response relationship in rats with h5F9-AM8 having an IC50 (UIBC) of approximately 80-fold higher than ABT-207. When hepcidin levels were downregulated, iron deposition in the liver was visible histologically 1 week post application. These antibody-mediated iron depositions were not associated with any adverse toxicologically relevant effect at the doses and time points evaluated. Iron depositions seen after 14 weekly treatments with ABT-207 were reversible in rats and in cynomolgus monkeys. Due to their long-lasting effects and excellent safety profile, both RGMc-blocking antibodies ABT-207 and h5F9-AM8 are favorable clinical candidates for diseases characterized by high serum hepcidin levels like anemia of chronic disease. | ||
| 700 | 1 | |a Hafner, Mathias |d 1956- |e VerfasserIn |0 (DE-588)1027781187 |0 (DE-627)729718379 |0 (DE-576)375302956 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Association of Pharmaceutical Scientists |t The AAPS journal |d Arlington, Va. : Soc., 2004 |g 17(2015), 4, Seite 930-938 |h Online-Ressource |w (DE-627)474385221 |w (DE-600)2170248-2 |w (DE-576)281264910 |x 1550-7416 |7 nnas |
| 773 | 1 | 8 | |g volume:17 |g year:2015 |g number:4 |g pages:930-938 |g extent:9 |a Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1208/s12248-015-9770-4 |x Verlag |x Resolving-System |z teilw. kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1208/s12248-015-9770-4 |x Verlag |z teilw. kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180118 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1027781187 |a Hafner, Mathias |m 1027781187:Hafner, Mathias |d 60000 |e 60000PH1027781187 |k 0/60000/ |p 6 | ||
| 999 | |a KXP-PPN1567330754 |e 2993109960 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Preethne Böser, Dietmar Seemann, Michael J. Liguori, Leimin Fan, Lili Huang, Mathias Hafner, Andreas Popp, and Bernhard K. Mueller"]},"id":{"doi":["10.1208/s12248-015-9770-4"],"eki":["1567330754"]},"physDesc":[{"extent":"9 S."}],"recId":"1567330754","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"22 April 2015"}],"relHost":[{"corporate":[{"display":"American Association of Pharmaceutical Scientists","role":"aut"}],"titleAlt":[{"title":"PharmSci"}],"pubHistory":["6.2004,3 -"],"id":{"zdb":["2170248-2"],"issn":["1550-7416"],"eki":["474385221"]},"part":{"volume":"17","year":"2015","extent":"9","text":"17(2015), 4, Seite 930-938","issue":"4","pages":"930-938"},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisherPlace":"Arlington, Va. ; New York, NY","publisher":"Soc. ; Springer"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 23.07.19"],"title":[{"subtitle":"a publication of the American Association of Pharmaceutical Scientists","title":"The AAPS journal","title_sort":"AAPS journal"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"474385221","disp":"American Association of Pharmaceutical ScientistsThe AAPS journal"}],"person":[{"display":"Böser, Preethne","role":"aut","given":"Preethne","family":"Böser"},{"display":"Hafner, Mathias","role":"aut","given":"Mathias","family":"Hafner"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 18.01.2018"],"title":[{"title_sort":"Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation","title":"Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation"}]} | ||
| SRT | |a BOESERPREEANTIREPULS2220 | ||